Recruiting Schizophrenia Studies in Los Angeles
About Schizophrenia Clinical Trials in Los Angeles
Schizophrenia is a chronic brain disorder affecting approximately 2.8 million US adults, characterized by hallucinations, delusions, disorganized thinking, and cognitive difficulties. While current treatments rely primarily on first- and second-generation antipsychotics (risperidone, olanzapine, clozapine), many patients experience incomplete symptom relief or significant side effects. Clinical trials are testing novel mechanisms including muscarinic receptor agonists (like KarXT/xanomeline-trospium), trace amine-associated receptor 1 (TAAR1) agonists, glutamate modulators, and long-acting injectable formulations. Treatment-resistant schizophrenia remains a major focus area, with trials seeking patients who have not adequately responded to standard antipsychotic therapy.
There are currently 11 schizophrenia clinical trials recruiting participants in Los Angeles, CA. These studies are seeking a combined 2,224 participants. Research is being sponsored by MapLight Therapeutics, Newron Pharmaceuticals SPA, Karuna Therapeutics, Inc., a Bristol Myers Squibb company and 6 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.
Schizophrenia Clinical Trials in Los Angeles — FAQ
Are there schizophrenia clinical trials in Los Angeles?
Yes, there are 11 schizophrenia clinical trials currently recruiting in Los Angeles, CA. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Los Angeles?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Los Angeles research site will contact you about next steps.
Are clinical trials in Los Angeles free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Los Angeles studies also compensate for your time and travel.
What schizophrenia treatments are being tested?
The 11 active trials in Los Angeles are testing new therapies including novel drugs, biologics, and treatment approaches for schizophrenia.
Data updated August 29, 2026 from ClinicalTrials.gov